Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$144.85
▲ $0.92 (+0.64%) today
Markets closed · 5:16am ET

MRK Coverage

Page 27
10:20am ET
Health and Healthcare

How Keytruda Saved Merck’s Q1

Merck released better-than-expected quarterly results and full-year guidance before the markets opened on Tuesday.

MRK
Chris Lange
10:05am ET
Health and Healthcare

Merck Moves Ahead With Late-Stage Trial Win

Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for the treatment of metastatic non-small cell lung cancer met its primary endpoint.

MRK
Chris Lange